The 13-valent pneumococcal conjugate vaccine (PCV13) is no longer recommended for routine use among adults aged ≥65 years, according to research published in the Nov. 22 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report. Almea Matanock, M.D., from the CDC in Atlanta, and colleagues reviewed evidence accrued during the...